Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-100
Closed -$8K – 857
2019
Q3
$8K Hold
100
– – ﹤0.01% 575
2019
Q2
$8K Buy
+100
New +$7.97K ﹤0.01% 563
2019
Q1
– Sell
-315
Closed -$21K – 801
2018
Q4
$21K Hold
315
– – ﹤0.01% 504
2018
Q3
$25K Hold
315
– – ﹤0.01% 564
2018
Q2
$21K Hold
315
– – ﹤0.01% 486
2018
Q1
$24K Hold
315
– – ﹤0.01% 452
2017
Q4
$21K Hold
315
– – ﹤0.01% 493
2017
Q3
$20K Hold
315
– – ﹤0.01% 449
2017
Q2
$17K Buy
+315
New +$16.4K ﹤0.01% 428

Other funds holding XYL

Capital Bank & Trust's XYL Position: Q4 2019 in Review

Capital Bank & Trust sold out of Xylem (XYL) in Q4 2019, closing a stake of 100 shares — an estimated $8K sold.

Capital Bank & Trust first reported a position in XYL in Q2 2017 and held it in 9 quarters. The position peaked at $25K in Q3 2018. 712 funds tracked by Wall St. Rank hold XYL as of Q4 2019.

  • Capital Bank & Trust reported no remaining Xylem position as of Q4 2019 after selling out during the quarter.
  • Capital Bank & Trust sold 100 Xylem shares in Q4 2019, an estimated $8K.
  • Capital Bank & Trust first reported a position in Xylem in Q2 2017 and held it in 9 quarters.
  • Capital Bank & Trust's Xylem position peaked at $25K in Q3 2018.
  • 712 funds tracked by Wall St. Rank held Xylem as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.